Everardo Cobos to Antineoplastic Agents
This is a "connection" page, showing publications Everardo Cobos has written about Antineoplastic Agents.
Connection Strength
1.399
-
Calderon A, Goyal S, Loayza Pintado J, Cantazaro B, Cobos E. Ulcers and Eosinophils: A Rare Presentation of PDGFRA-Rearranged Myeloid Neoplasm Responding to Imatinib. J Investig Med High Impact Case Rep. 2026 Jan-Dec; 14:23247096251414051.
Score: 0.522
-
Aura C, Salcedo L, Loayza Pintado J, Matos C, Mogollon I, Arias F, Cobos E. Silent damage, early signals: A narrative review of the evolving role of cardiac biomarkers in oncology-driven cardiotoxicity. J Investig Med. 2026 May; 74(4):299-308.
Score: 0.510
-
Li W, Frame LT, Hoo KA, Li Y, D'Cunha N, Cobos E. Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro. Leuk Lymphoma. 2011 Dec; 52(12):2380-90.
Score: 0.191
-
Moosavi L, Bowen J, Coleman J, Heidari A, Cobos E. Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619872657.
Score: 0.080
-
Kim M, Mirandola L, Pandey A, Nguyen DD, Jenkins MR, Turcel M, Cobos E, Chiriva-Internati M. Application of vitamin D and derivatives in hematological malignancies. Cancer Lett. 2012 Jun 01; 319(1):8-22.
Score: 0.049
-
Mirandola L, Yu Y, Chui K, Jenkins MR, Cobos E, John CM, Chiriva-Internati M. Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma. PLoS One. 2011; 6(7):e21811.
Score: 0.048